Zymeworks (ZYME) Other Non-Current Liabilities (2021 - 2026)
Zymeworks' Other Non-Current Liabilities was $278,000 in Q2 2026, down 66.4% from $828,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Zymeworks (ZYME) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
From Q4 2021 onward, Zymeworks has reported Other Non-Current Liabilities for 17 quarters.
- Other Non-Current Liabilities has now declined for three consecutive years, with a four-year compound annual growth rate of -43.6% (FY2021 to FY2025).
- In earlier years, Other Non-Current Liabilities was $923,000 in FY2024 (-45.7%), $1.7 million in FY2023 (-45.1%), $3.1 million in FY2022 (+12.8%) and $2.75 million in FY2021.
- Quarterly Other Non-Current Liabilities has moved between $278,000 (Q3 2025) and $3.6 million (Q2 2023) over five years.
- Compared with a year earlier, Other Non-Current Liabilities has declined for 12 straight quarters, with an average decline of 56.1% over the last eight quarters.
- The best year-over-year quarter for Other Non-Current Liabilities over five years was Q4 2022 (growth of 12.8%); the worst was Q3 2025 (a decline of 70.1%).
- Per Business Quant data, ZYME's Other Non-Current Liabilities in the three quarters before Q2 2026 was $278,000 (Q1 2026), $278,000 (Q4 2025) and $278,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Zymeworks | 2.05 Bn | 936.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 278,000.00 |
| Mar 31, 2026 | 278,000.00 |
| Dec 31, 2025 | 278,000.00 |
| Sep 30, 2025 | 278,000.00 |
| Jun 30, 2025 | 828,000.00 |
| Mar 31, 2025 | 856,000.00 |
| Dec 31, 2024 | 923,000.00 |
| Sep 30, 2024 | 929,000.00 |
| Jun 30, 2024 | 1.23 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | 1.70 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | 3.60 Mn |
| Mar 31, 2023 | 3.60 Mn |
| Dec 31, 2022 | 3.10 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Dec 31, 2021 | 2.75 Mn |
API Access
Zymeworks Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ZYME&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ZYME", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ZYME&period=max&api_key=YOUR_API_KEY");
const data = await res.json();